BackAlzamend Neuro Overview

Alzamend Neuro Total Liabilities

Latest total liabilities for ALZN: $1.3M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.35M

Peer trimmed avg / median

Loading

Alzamend Neuro Total Liabilities History

Loading

Alzamend Neuro vs. peers: Total Liabilities Comparison

Loading

Alzamend Neuro Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Alzamend Neuro (ALZN) FAQ

Alzamend Neuro (ALZN) currently reports a total liabilities of $1.3M as of April 2026. Use the charts on this page to explore Alzamend Neuro's total liabilities history and peer comparisons.

Alzamend Neuro reported $1.3M in total liabilities as of April 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $1.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alzamend Neuro, and consider following ALZN for alerts when major investors trade the stock.

Alzamend Neuro is classified in the Healthcare sector. On total liabilities, it currently shows $1.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALZN with unrelated industries.